JP2016503067A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016503067A5 JP2016503067A5 JP2015549834A JP2015549834A JP2016503067A5 JP 2016503067 A5 JP2016503067 A5 JP 2016503067A5 JP 2015549834 A JP2015549834 A JP 2015549834A JP 2015549834 A JP2015549834 A JP 2015549834A JP 2016503067 A5 JP2016503067 A5 JP 2016503067A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- cdr
- acid sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261745239P | 2012-12-21 | 2012-12-21 | |
| US61/745,239 | 2012-12-21 | ||
| PCT/US2013/077264 WO2014100740A1 (en) | 2012-12-21 | 2013-12-20 | Anti-ntb-a antibodies and related compositions and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018203019A Division JP6817674B2 (ja) | 2012-12-21 | 2018-10-29 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016503067A JP2016503067A (ja) | 2016-02-01 |
| JP2016503067A5 true JP2016503067A5 (2) | 2017-01-12 |
| JP6449777B2 JP6449777B2 (ja) | 2019-01-09 |
Family
ID=50979291
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015549834A Expired - Fee Related JP6449777B2 (ja) | 2012-12-21 | 2013-12-20 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2018203019A Expired - Fee Related JP6817674B2 (ja) | 2012-12-21 | 2018-10-29 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2019238780A Withdrawn JP2020055870A (ja) | 2012-12-21 | 2019-12-27 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2022038055A Withdrawn JP2022066565A (ja) | 2012-12-21 | 2022-03-11 | 抗ｎｔｂ－ａ抗体ならびに関連する組成物および方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018203019A Expired - Fee Related JP6817674B2 (ja) | 2012-12-21 | 2018-10-29 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2019238780A Withdrawn JP2020055870A (ja) | 2012-12-21 | 2019-12-27 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2022038055A Withdrawn JP2022066565A (ja) | 2012-12-21 | 2022-03-11 | 抗ｎｔｂ－ａ抗体ならびに関連する組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9708404B2 (2) |
| EP (1) | EP2934585B1 (2) |
| JP (4) | JP6449777B2 (2) |
| CN (2) | CN105188749B (2) |
| AU (1) | AU2013364043B2 (2) |
| CA (1) | CA2893977C (2) |
| EA (1) | EA031025B1 (2) |
| HK (1) | HK1216850A1 (2) |
| IL (2) | IL239211B (2) |
| WO (1) | WO2014100740A1 (2) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2700141T3 (es) * | 2007-08-02 | 2019-02-14 | Gilead Biologics Inc | Anticuerpos inhibidores LOXL2 y usos de los mismos |
| CN105188749B (zh) * | 2012-12-21 | 2017-12-19 | 西雅图基因公司 | 抗ntb‑a抗体及相关组合物和方法 |
| US9603927B2 (en) | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
| US9732154B2 (en) | 2014-02-28 | 2017-08-15 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia |
| KR20170058960A (ko) * | 2014-09-09 | 2017-05-29 | 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 | Agr2 및 그의 수용체 c4.4a 에 대한 차단 모노클로날 항체 |
| JP6214790B2 (ja) * | 2014-09-16 | 2017-10-18 | イース チャーム リミテッド | 抗ｅｇｆｒ抗体および同抗体の使用法 |
| EP3200822B1 (en) * | 2014-09-30 | 2021-04-14 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Binding molecules, especially antibodies, binding to l1cam (cd171) |
| AU2015339012B2 (en) | 2014-10-31 | 2020-11-05 | Abbvie Biotherapeutics Inc. | Anti-CS1 antibodies and antibody drug conjugates |
| CN107406506A (zh) | 2014-12-04 | 2017-11-28 | 詹森生物科技公司 | 用于治疗急性髓系白血病的抗cd38抗体 |
| EA201792546A1 (ru) | 2015-05-20 | 2018-04-30 | Янссен Байотек, Инк. | Антитела к cd38 для лечения амилоидоза легких цепей и прочих cd38-положительных гематологических злокачественных опухолей |
| US20170044265A1 (en) * | 2015-06-24 | 2017-02-16 | Janssen Biotech, Inc. | Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38 |
| SG10202005460RA (en) * | 2015-06-30 | 2020-07-29 | Seattle Genetics Inc | Anti-ntb-a antibodies and related compositions and methods |
| CA3004152C (en) | 2015-11-03 | 2024-04-16 | Janssen Biotech, Inc. | Subcutaneous formulations of anti-cd38 antibodies and their uses |
| US20190233533A1 (en) | 2016-06-28 | 2019-08-01 | Umc Utrecht Holding B.V. | Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38 |
| MA50514A (fr) | 2017-10-31 | 2020-09-09 | Janssen Biotech Inc | Méthodes de traitement du myélome multiple à haut risque |
| AU2019221544B2 (en) * | 2018-02-13 | 2025-07-10 | Precision Biologics, Inc. | Methods and compositions for targeting Treg cells |
| AU2020298833A1 (en) | 2019-07-03 | 2022-01-20 | Oxford Biotherapeutics Ltd | Antibodies and methods of use |
| EP4017542A1 (en) * | 2019-10-04 | 2022-06-29 | Tae Life Sciences | Antibody compositions comprising fc mutations and site-specific conjugation properties |
| US20230092356A1 (en) | 2019-12-06 | 2023-03-23 | Thoas Fioretos | Novel agents and uses thereof |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5515508A (en) | 1993-12-17 | 1996-05-07 | Taligent, Inc. | Client server system and method of operation including a dynamically configurable protocol stack |
| AU5752696A (en) * | 1995-05-18 | 1996-11-29 | Regents Of The University Of Michigan, The | Dna binding antibodies |
| MA24512A1 (fr) | 1996-01-17 | 1998-12-31 | Univ Vermont And State Agrienl | Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose |
| WO2001053466A1 (en) | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| WO2001055336A2 (en) | 2000-01-25 | 2001-08-02 | Hyseq, Inc. | Methods and materials relating to cd84-like polypeptides and polynucleotides |
| AU2001253362A1 (en) | 2000-04-13 | 2001-10-30 | Smith Kline Beecham Corporation | Novel compounds |
| AU2001274888A1 (en) | 2000-05-19 | 2001-12-03 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| US6464770B1 (en) | 2000-08-08 | 2002-10-15 | Advanced Minerals Corporation | Perlite products with controlled particle size distribution |
| JP4451059B2 (ja) | 2000-09-01 | 2010-04-14 | ジェネンテック インコーポレイテッド | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| US7795412B2 (en) | 2000-09-15 | 2010-09-14 | Genentech, Inc. | Nucleic acids encoding PRO6308 polypeptides and related vectors and host cells |
| EP1223218A1 (en) | 2000-11-03 | 2002-07-17 | Millennium Pharmaceuticals, Inc. | CD2000 and CD2001 molecules and uses thereof |
| US20030180888A1 (en) | 2000-11-03 | 2003-09-25 | Millennium Pharmaceuticals, Inc. | CD2000 and CD2001 molecules, and uses thereof |
| US7892730B2 (en) | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
| JP2004533222A (ja) | 2001-03-12 | 2004-11-04 | インサイト・ゲノミックス・インコーポレイテッド | 免疫グロブリンスーパーファミリータンパク質 |
| US7138243B2 (en) | 2001-07-19 | 2006-11-21 | Innate Pharma, S.A. | NTB-A, a surface molecule involved in natural killer cells activity |
| MXPA04001986A (es) | 2001-08-29 | 2004-06-07 | Genentech Inc | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. |
| US20060194265A1 (en) | 2001-10-23 | 2006-08-31 | Morris David W | Novel therapeutic targets in cancer |
| CA2476555A1 (en) | 2002-02-14 | 2003-08-21 | Nuvelo, Inc. | Methods of therapy and diagnosis |
| WO2004004649A2 (en) | 2002-07-08 | 2004-01-15 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| DK1545613T3 (da) | 2002-07-31 | 2011-11-14 | Seattle Genetics Inc | Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom |
| AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| CA2500521A1 (en) | 2002-10-02 | 2004-09-23 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| WO2005019258A2 (en) | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| EP2478912B1 (en) | 2003-11-06 | 2016-08-31 | Seattle Genetics, Inc. | Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
| US20080299042A1 (en) | 2004-04-30 | 2008-12-04 | Biogen Idec Ma Inc. | Membrane Associated Molecules |
| MX2007000998A (es) | 2004-07-30 | 2007-07-11 | Rinat Neuroscience Corp | Anticuerpos dirigidos peptido beta-amiloide y procedimientos que usan los mismos. |
| ES2708763T3 (es) | 2005-07-07 | 2019-04-11 | Seattle Genetics Inc | Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C |
| WO2007008848A2 (en) | 2005-07-07 | 2007-01-18 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus |
| EP2354163A3 (en) * | 2005-09-26 | 2013-04-24 | Medarex, Inc. | Conjugates of duocarmycin and anti-CD70 or anti-PSMA antibodies |
| TW200823237A (en) * | 2006-08-28 | 2008-06-01 | Nuvelo Inc | Antibodies to NTB-A |
| US8375932B2 (en) * | 2007-10-03 | 2013-02-19 | Germans Boada, S.A. | Manual ceramics cutter |
| AR068723A1 (es) * | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| DK2211904T3 (en) | 2007-10-19 | 2016-10-24 | Seattle Genetics Inc | Cd19-binding agents and uses thereof |
| RU2011111640A (ru) | 2008-08-29 | 2012-10-10 | Симфоген А/С (Dk) | Антитела против cd5 |
| CN102333859B (zh) * | 2008-09-16 | 2015-04-22 | 三井化学株式会社 | 由来自植物的原料生产乳酸的方法及生产乳酸的细菌 |
| US20120128689A1 (en) | 2009-04-01 | 2012-05-24 | Glaxo Group Limited | Anti-il-23 immunoglobulins |
| EP2443150B1 (en) | 2009-06-17 | 2015-01-21 | AbbVie Biotherapeutics Inc. | Anti-vegf antibodies and their uses |
| US8221753B2 (en) | 2009-09-30 | 2012-07-17 | Tracon Pharmaceuticals, Inc. | Endoglin antibodies |
| US8303093B2 (en) * | 2009-12-15 | 2012-11-06 | Xerox Corporation | Print head having a polymer layer to facilitate assembly of the print head |
| BR112012017696A2 (pt) | 2010-01-18 | 2017-10-03 | Novo Nordisk Healthcare Ag | Purificação de fatores de coagulação de sangue |
| UA108227C2 (xx) * | 2010-03-03 | 2015-04-10 | Антигензв'язуючий білок | |
| US8986697B2 (en) | 2010-04-15 | 2015-03-24 | Progenics Pharmaceuticals, Inc. | Antibodies for the treatment of Clostridium difficile-associated infection and disease |
| US9243057B2 (en) * | 2010-08-31 | 2016-01-26 | The Regents Of The University Of California | Antibodies for botulinum neurotoxins |
| TWI452136B (zh) * | 2010-11-17 | 2014-09-11 | 中外製藥股份有限公司 | A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation |
| EP2643350A4 (en) | 2010-11-22 | 2015-01-07 | Innate Pharma Sa | TREATMENTS WITH NK CELL MODULATION AND METHOD FOR THE TREATMENT OF HEMATOLOGICAL MALIGNOMES |
| WO2013008171A1 (en) | 2011-07-11 | 2013-01-17 | Glenmark Pharmaceuticals S.A. | Antibodies that bind to ox40 and their uses |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| CN105188749B (zh) * | 2012-12-21 | 2017-12-19 | 西雅图基因公司 | 抗ntb‑a抗体及相关组合物和方法 |
| EP2824112B1 (en) * | 2013-07-10 | 2016-12-21 | Miltenyi Biotec GmbH | Method for inducing proliferation of Natural Killer cells by mobile nanomatrices |
| SG10202005460RA (en) * | 2015-06-30 | 2020-07-29 | Seattle Genetics Inc | Anti-ntb-a antibodies and related compositions and methods |
-
2013
- 2013-12-20 CN CN201380073489.9A patent/CN105188749B/zh not_active Expired - Fee Related
- 2013-12-20 EA EA201591191A patent/EA031025B1/ru unknown
- 2013-12-20 CN CN201711276208.6A patent/CN107880126B/zh not_active Expired - Fee Related
- 2013-12-20 EP EP13863944.8A patent/EP2934585B1/en active Active
- 2013-12-20 AU AU2013364043A patent/AU2013364043B2/en not_active Ceased
- 2013-12-20 US US14/758,430 patent/US9708404B2/en active Active
- 2013-12-20 CA CA2893977A patent/CA2893977C/en active Active
- 2013-12-20 JP JP2015549834A patent/JP6449777B2/ja not_active Expired - Fee Related
- 2013-12-20 WO PCT/US2013/077264 patent/WO2014100740A1/en not_active Ceased
- 2013-12-20 HK HK16104822.8A patent/HK1216850A1/zh unknown
-
2015
- 2015-06-04 IL IL239211A patent/IL239211B/en active IP Right Grant
-
2017
- 2017-06-14 US US15/622,411 patent/US10435468B2/en active Active
-
2018
- 2018-10-29 JP JP2018203019A patent/JP6817674B2/ja not_active Expired - Fee Related
-
2019
- 2019-08-28 US US16/553,525 patent/US20190375841A1/en not_active Abandoned
- 2019-12-10 IL IL271305A patent/IL271305B/en active IP Right Grant
- 2019-12-27 JP JP2019238780A patent/JP2020055870A/ja not_active Withdrawn
-
2022
- 2022-03-11 JP JP2022038055A patent/JP2022066565A/ja not_active Withdrawn
- 2022-08-15 US US17/819,819 patent/US20230105802A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503067A5 (2) | ||
| JP6526189B2 (ja) | 抗ｐｄ−ｌ１抗体並びにその治療及び診断のための使用 | |
| JP2016536020A5 (2) | ||
| JP2016538318A5 (2) | ||
| JP2021501162A5 (2) | ||
| HRP20240924T1 (hr) | Anti - sirpalpha antitijela | |
| JP2020513791A5 (2) | ||
| IL266756A (en) | Human monoclonal antibodies that bind to MASP 2 and suppress MASP-dependent complement activation, methods for their production and uses | |
| JP2018519263A5 (2) | ||
| JP2021527431A5 (2) | ||
| JP2017534256A5 (2) | ||
| RU2017121327A (ru) | Комбинированная терапия на основе активирующих т-клетки биспецифических антигенсвязывающих молекул против cd3 и фолатного рецептора 1 (folr1) и антагонистов, связывающихся с осью pd-1 | |
| JP2016512551A5 (2) | ||
| JP2015520758A5 (2) | ||
| JP2024056687A5 (2) | ||
| JP2011046732A5 (2) | ||
| JP2020503260A5 (2) | ||
| RU2008149918A (ru) | Антитела к nkg2a и их применения | |
| JP2020504723A5 (2) | ||
| JP2015509947A5 (2) | ||
| PE20140848A1 (es) | Anticuerpos monoclonales contra la proteina rgma y sus usos | |
| JP2014533659A5 (2) | ||
| JP2016531915A5 (2) | ||
| JP2018513149A5 (2) | ||
| JP2017526370A5 (2) |